Clinical Immunoanalyzer detect and quantify specific analytes in blood or in samples of body fluids by utilizing immunoassay methodologies such as immunoprecipitation, particle immunoassays, immunonephelometry, radioimmunoassay, enzyme immunoassay, fluorescent immunoassay, and chemiluminescent immunoassays.
The global average price of clinical immunoanalyzer is in the decrease trend, from 19.36 K USD/Unit in 2012 to 19.19 K USD/Unit in 2016.
The classification of Clinical immunoanalyzer includes CLIA, ELISA, RIA, FIA and Other, and the proportion of CLIA in 2016 is about 46%, and the proportion is in increasing trend from 2012 to 2016.
Clinical immunoanalyzer is widely used in Hospital, Clinic and Other Institutions. The most proportion of clinical immunoanalyzer is used in Hospital, and the consumption proportion is about 72%.
North America is the largest consumption place, with a consumption market share nearly 36% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 27%.
Market competition is intense. Roche Diagnostics, Abbott, Siemens, Beckman Coulter, Ortho-Clinical Diagnostics etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The report offers detailed coverage of Clinical Immunoanalyzer industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Clinical Immunoanalyzer by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
The report forecast global Clinical Immunoanalyzer market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.
First, this report covers the present status and the future prospects of the global Clinical Immunoanalyzer market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Roche Diagnostics
Abbott
Siemens
Beckman Coulter
Ortho-Clinical Diagnostics
Bio-Rad
BioMerieux
DiaSorin
Werfen Life
Thermo Fisher Scientific
Tosoh Corporation
Randox Laboratories
Snibe
Transasia
At the same time, we classify Clinical Immunoanalyzer according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows:
Market by Order Type
CLIA
ELISA
RIA
FIA
Other
Market by Application
Hospital
Clinic
Other
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Clinical Immunoanalyzer market for the forecast period 2021 - 2025?
• What are the driving forces in the Clinical Immunoanalyzer market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Clinical Immunoanalyzer industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?